2,4-thiazolidinedione has been researched along with Fatty Liver, Nonalcoholic in 6 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The outcomes were liver biopsy-based (NAFLD activity score [NAS], fibrosis stage, and NASH resolution), noninvasive technique-based (liver fat content on proton magnetic resonance spectroscopy [1H-MRS] and controlled attenuation parameter [CAP]), biological, and anthropometric indicators." | 3.01 | Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis. ( Kim, H; Kim, K; Kim, MG; Park, MJ, 2023) |
| "Non-alcoholic fatty liver disease (NAFLD) is a major national and international health burden." | 2.61 | Position statement on the diagnosis and management of non-alcoholic fatty liver disease. ( Al-Hamoudi, WK; Al-Judaibi, B; Al-Osaimi, A; Alswat, KA; Alturaify, N; Elsiesy, HA; Fallatah, HI; Qutub, AN, 2019) |
| "The prevalence of nonalcoholic fatty liver disease (NAFLD) has significantly increased over the last decades." | 2.53 | Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis. ( Chaiyakunapruk, N; Chongmelaxme, B; Kowdley, KV; Phisalprapa, P; Saokaew, S; Sawangjit, R; Thakkinstian, A, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Park, MJ | 1 |
| Kim, H | 1 |
| Kim, MG | 1 |
| Kim, K | 1 |
| Shannon, CE | 1 |
| Ragavan, M | 1 |
| Palavicini, JP | 1 |
| Fourcaudot, M | 1 |
| Bakewell, TM | 1 |
| Valdez, IA | 1 |
| Ayala, I | 1 |
| Jin, ES | 1 |
| Madesh, M | 1 |
| Han, X | 1 |
| Merritt, ME | 1 |
| Norton, L | 1 |
| Chitturi, S | 1 |
| Wong, VW | 1 |
| Chan, WK | 1 |
| Wong, GL | 1 |
| Wong, SK | 1 |
| Sollano, J | 1 |
| Ni, YH | 1 |
| Liu, CJ | 1 |
| Lin, YC | 1 |
| Lesmana, LA | 1 |
| Kim, SU | 1 |
| Hashimoto, E | 1 |
| Hamaguchi, M | 1 |
| Goh, KL | 1 |
| Fan, J | 1 |
| Duseja, A | 1 |
| Dan, YY | 1 |
| Chawla, Y | 1 |
| Farrell, G | 1 |
| Chan, HL | 1 |
| Alswat, KA | 1 |
| Fallatah, HI | 1 |
| Al-Judaibi, B | 1 |
| Elsiesy, HA | 1 |
| Al-Hamoudi, WK | 1 |
| Qutub, AN | 1 |
| Alturaify, N | 1 |
| Al-Osaimi, A | 1 |
| Takei, Y | 1 |
| Sawangjit, R | 1 |
| Chongmelaxme, B | 1 |
| Phisalprapa, P | 1 |
| Saokaew, S | 1 |
| Thakkinstian, A | 1 |
| Kowdley, KV | 1 |
| Chaiyakunapruk, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation[NCT04455932] | 476 participants (Anticipated) | Interventional | 2022-01-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for 2,4-thiazolidinedione and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis.
Topics: Adult; Glucagon-Like Peptide-1 Receptor; Humans; Network Meta-Analysis; Non-alcoholic Fatty Liver Di | 2023 |
The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups.
Topics: Adolescent; Asia; Bariatric Surgery; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Child; Diet; | 2018 |
Position statement on the diagnosis and management of non-alcoholic fatty liver disease.
Topics: Bariatric Surgery; Biomarkers; Biopsy; Chalcones; Chenodeoxycholic Acid; Diagnostic Imaging; Healthy | 2019 |
Treatment of non-alcoholic fatty liver disease.
Topics: Animals; Fatty Liver; Humans; Inflammation; Insulin Resistance; Life Style; Liver Transplantation; M | 2013 |
Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis.
Topics: Antioxidants; Chenodeoxycholic Acid; Humans; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Thia | 2016 |
1 other study available for 2,4-thiazolidinedione and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease.
Topics: Animals; Blood Glucose; Cardiolipins; Citric Acid Cycle; Diabetes Mellitus, Type 2; Fatty Acids; Hep | 2021 |